UGT2B17-deletion may 1) reduce a person’s ability to detoxify smoking-associated metabolites, 2) allow cellular DNA to become exposed to high levels of carcinogens in cigarettes and cigarette smoke, and 3) raise the probability of DNA injury, and thus increase the risk of TP53-mutations, resulting in tumor development. The gene discussed is TP53; the disease is neoplasm.